Ivabradine hydrochloride sustained-release pellet as well as preparation method and application thereof

CN119587509APending Publication Date: 2025-03-11JIANGSU NOVO-BITO PHAMMACEUTICAL RESEARCH CO LTD

Patent Information

Application Number
CN202411585352.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-11-08
Publication Date
2025-03-11

Smart Images

  • Figure CN119587509A_ABST
    Figure CN119587509A_ABST
Patent Text Reader

Abstract

The invention provides an ivabradine hydrochloride sustained-release pellet and a preparation method and application thereof, and belongs to the technical field of pharmaceutical preparations, drugs are prepared into a sustained-release pellet preparation, the peak valley phenomenon of the plasma concentration of a common preparation can be effectively avoided, the plasma concentration can be kept for a long time, the medicine taking frequency is reduced, and the adverse reaction occurrence rate is reduced. The compliance of a patient is improved; the sustained-release pellet preparation provided by the invention belongs to a multi-unit sustained-release preparation, can avoid sudden release of drugs, and further ensures the safety of clinical medication; and the product has good stability and is equivalent to a commercially available quick-release preparation, namely, Lane. The preparation process is simple, ethanol used in the process is a conventional solvent, compared with other dichloromethane, acetone and the like, the toxicity is small, the safety is high, the technical difficulty is reduced, industrial mass production is easy to realize, and the market potential is large.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • A sustained-release formulation of ivabradine hydrochloride, its preparation method and application

    CN112294777B

Cited By

  • Compound ambroxterol sustained-release pellet and preparation method thereof

    CN122351182A